Perbedaan Status Fungsional Pada Pasien Stroke Iskemik yang Menggunakan Terapi Statin di RSUP Dr. M. Djamil Padang
| dc.contributor.advisor | Rahmi, Yosmar | |
| dc.contributor.author | Raudhatul, Jannah | |
| dc.date.accessioned | 2026-09-24T22:19:05Z | |
| dc.date.issued | 2021-08-23 | |
| dc.description | apt. Rahmi Yosmar, M. Farm | |
| dc.description.abstract | Stroke Iskemik merupakan sekumpulan tanda klinik yang berkembang sebab arteri yang membawa darah dari jantung dan paru-paru tersumbat menuju otak. Terapi untuk mencegah terjadinya stroke adalah mengurangi kadar kolesterol terutama Low Density Lipoprotein dengan statin. Penelitian ini bertujuan untuk mengetahui karakteristik sosiodemografi pasien stroke iskemik, mengetahui pola penggunaan statin yang diberikan pada pasien, dan mengetahui perbedaan status fungsional pasien stroke iskemik sebelum dan setelah penggunaan statin. Penelitian ini merupakan penelitian deskriptif dan analitik, dengan pendekatan secara retrospektif. Jumlah pasien yang memenuhi kriteria inklusi sebanyak 58 pasien. Hasil penelitian menunjukkan bahwa pasien stroke iskemik yang paling banyak banyak menerima terapi statin adalah, laki-laki sebanyak 58,62%, berusia 56-65 tahun sebanyak 34,48%, pendidikan terakhir adalah Sekolah Menengah Atas sebanyak 50%, dan pekerjaan adalah ibu rumah tangga sebanyak 30,89%. Penggunaan obat golongan statin yang paling banyak digunakan adalah atorvastatin sebesar 82,76%. Berdasarkan analisa statistik status fungsional sebelum dan sesudah pemberian terapi statin yang dikelompokkan berdasarkan tingkat ketergantungan dan jenis obat statin, didapatkan ada perbedaan signifikan status fungsional sebelum dan sesudah pemberian terapi. | |
| dc.identifier.uri | https://ailib.my.id/handle/123456789/62200 | |
| dc.language.iso | id | |
| dc.publisher | Universitas Andalas | |
| dc.subject | stroke iskemik | |
| dc.subject | statin | |
| dc.subject | status fungsional | |
| dc.subject.classification | RM Therapeutics. Pharmacology | |
| dc.subject.classification | RS Pharmacy and materia medica | |
| dc.title | Perbedaan Status Fungsional Pada Pasien Stroke Iskemik yang Menggunakan Terapi Statin di RSUP Dr. M. Djamil Padang | |
| dc.type | Thesis | |
| dcterms.dateSubmitted | 2021-12-01 | |
| dcterms.references | Rossi UG, Ierardi AM, Cariati M. Acute ischemic stroke. Acta Neurol Taiwan. 2019;28(3):84–5. Riskesdas. Laporan Provinsi Sumatera Barat Riskesdas 2018. Laporan Riskesdas Nasional. 2018. 493 p. Balitbang Kemenkes RI Provinsi Sumatra Barat. Dalam Angka Provinsi Sumatera Barat. 2013. 224–230 p. Ihsan S, Leorita M, Daud IY. Efektivitas Terapi Statin pada Pasien Pasca Stroke Iskemik ( Effectiveness of Statin Therapy in Ischemic Post Stroke Patients ). Pharmauho. 2020;6(1):27–32. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI). PANDUAN TATA LAKSANA DISLIPIDEMIA. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia; 2017. Alexxander A, Nugroho AE, Pinzon RT. Peranan Obat Golongan Statin Terhadap Luaran Status Fungsional Pasien Stroke Iskemik Berulang Di Rumah Sakit Bethesda Yogyakarta. Berk Ilm Kedokt Duta Wacana. 2017;2(3):445. Purnamasari R, Manggau MA, Amran MY. Hubungan Antara Penggunaan Obat Atorvastatin Terhadap Perbaikan Klinis Pasien Stroke Iskemik Di Rsup Dr. Wahidin Sudirohusodo. Maj Farm dan Farmakol. 2018;22(1):8–12. Dewi IP, Merry MS. Peranan Obat Golongan Statin. Berk Ilm Kedokt Duta Wacana. 2017;2(3):1. Julius F, Anwar Y, Darulkutni N. PENGARUH DOSIS STATIN TERHADAP KADAR LIPID PLASMA DAN OUTCOME FUNGSIONAL PADA PASIEN STROKE ISKEMIK. 2011;28(3). Marjoko BR, Utomo W, Hasanah O. Analisis Status Fungsional Pasien Stroke Saat Keluar Ruang Merak II RSUD Arifin Achmad Pekanbaru. 2008;21–3. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM. Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association RD on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2011;1231. Roge(4):18–209. Dinata CA, Safrita YS, Sastri S. Gambaran Faktor Risiko dan Tipe Stroke pada Pasien Rawat Inap di Bagian Penyakit Dalam RSUD Kabupaten Solok Selatan Periode 1 Januari 2010 - 31 Juni 2012. J Kesehat Andalas. 2013;2(2):57. 13. Hartono E, Puspitasari M, Adam O. Gambaran Tekanan Darah Pada Pasien Stroke Hemoragik Dengan Diabetes Melitus Dan Non Diabetes Melitus Di Bagian Saraf Rumkital Dr.Ramelan Surabaya. J Chem Inf Model. 2019;53(9):1689–99. 14. Wells BG, DiPiro JT, Schwinghammer TL, DiPiro C V. Pharmacotherapy Handbook,Tenth Edition. McGraw-Hill Companies. 2017. 1-8,787-797 p. 15. Goetz C. Textbook of Clinical Neurology. 3rd ed. Philadelphia: Saunders; 2007. 16. Brunner, Suddart. Keperawatan Medikal-Bedah. 12th ed. Jakarta: EGC; 2014. 17. Welty TE. Applied Therapeutics: The Clinical Use Of Drugs. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. 18. Price SA, Wilson LM. Konsep Klinis Proses-Proses Penyakit. In: Hartanto H, Wulansari P, Susi N, Mahanani DA, editors. Patofisiologi. 6th ed. Jakarta: EGC; 2005. p. 493–8. 19. American Stroke Association. Hemorrhagic Stroke (Bleeds) [Internet]. Stroke. 2020. Available from: https://www.stroke.org/en/about-stroke/types-of-stroke/hemorrhagic-strokes-bleeds 20. Black, J. M., & Hawks JH. Keperawatan Medikal Bedah: Manajemen klinis untuk Hasil yang Diharapkan. Edisi 8. Jakarta: Salemba Medika. 2018; 21. Harold P, Adams J. Classification of subtype of acute ischemic stroke. Stroke. 1993;24(1):35–41. 22. Roger L, Go AS, Lloyd-jones DM, Benjamin EJ, Berry JD, Borden WB. Executive Summary : Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association. 2012;188–97. 23. Kissela BM, J.C. K, Alwell K, Moomaw JC, Woo D, Adeoye O. Age at stroke. Neurol 1781-1787. 2012;79(17):1781–7. 24. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol [Internet]. 2010;9(2):167–76. Available from: http://dx.doi.org/10.1016/S1474-4422(09)70340-0 25. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C. Sex differences in stroke care and outcomes: Results from the Registry of the Canadian Stroke Network. Stroke. 2005;36(4):809–14. 26. Reeves MJ, Fonarow GC, Zhao X, Smith EE, Schwamm LH. Quality of care in women with ischemic stroke in the GWTG program. Stroke. 2009;40(4):1127–33. 27. Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Eden S V. Differences in intracerebral hemorrhage between Mexican Americans and non-Hispanic whites. Neurology. 2006;66(1):30–4. 28. Cruz-Flores S, Rabinstein A, Biller J, Elkind MSV, Griffith P, Gorelick PB. Racial-ethnic disparities in stroke care: The American experience: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(7):2091–116. 29. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K. Stroke in a Biracial Population: The Excess Burden of Stroke among Blacks. Stroke. 2004;35(2):426–31. 30. Kleindorfer D, Broderick J, Khoury J, Flaherty M, Woo D, Alwell K. The unchanging incidence and case-fatality of stroke in the 1990s: A population-based study. Stroke. 2006;37(10):2473–8. 31. Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB. Incidence and risk factors for stroke in american indians the strong heart study. Circulation. 2008;118(15):1577–84. 32. Seshadri S, Beiser A, Pikula A, Himali JJ, Kelly-Hayes M, Debette S. Parental occurrence of stroke and risk of stroke in their children: The framingham study. Circulation. 2010;121(11):1304–12. 33. Yu JG, Zhou RR, Cai GJ. From Hypertension to Stroke: Mechanisms and Potential Prevention Strategies. CNS Neurosci Ther. 2011;17(5):577–84. 34. Yonata A, Pratama ASP. Hipertensi sebagai Faktor Pencetus Terjadinya Stroke. J Major [Internet]. 2016;5(3):17–21. Available from: http://juke.kedokteran.unila.ac.id/index.php/majority/article/view/1030 35. Nazim Khan M, Dilruba Khan H, Ahmad M, Umar M. Serum Total and HDL-Cholesterol in Ischemic and Hemorrhagic Stroke Serum Total and HDL-Cholesterol in Ischemic and Hemorrhagic Stroke Address for Correspondence. Inst Med Sci. 2014;10(1):22–6. 36. Pak A, Taheed Baluch U, Kiani I, Badshah M. Association of Dyslipidemia and Ischemic Stroke Urooj Taheed Baluch et al Association of Dyslipidemia and Ischemic Stroke. Inst Med Sci. 2008;4(3):165–7. 37. Wang X, Dong Y, Qi X, Huang C, Hou L. Cholesterol levels and risk of hemorrhagic stroke: A systematic review and meta-analysis. Stroke. 2013;44(7):1833–9. 38. Wieberdink RG, Poels MMF, Vernooij MW, Koudstaal PJ, Hofman A, Van Der Lugt A, et al. Serum lipid levels and the risk of intracerebral hemorrhage: The Rotterdam study. Arterioscler Thromb Vasc Biol. 2011;31(12):2982–9. 39. Arboix A. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases. 2015;3(5):418. 40. Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS. Abdominal obesity and risk of ischemic stroke: The Northern Manhattan Stroke Study. Stroke. 2003;34(7):1586–92. 41. Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129(21):2094–9. 42. Ringleb PA, Bousser MG, Ford G, Bath P, Brainin M, Caso V. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457–507. 43. Lavie L, Lavie P. Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med. 2008;9(3):247–53. 44. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003;46(1):11–29. 45. Arenillas JF, Moro MA, Dávalos A. The metabolic syndrome and stroke: Potential treatment approaches. Stroke. 2007;38(7):2196–203. 46. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD. Primary prevention of ischemic stroke. A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Counc. Vol. 37, Stroke. 2006. 1583–1633 p. 47. Allen CL, Bayraktutan U. Risk factors for ischaemic stroke. Int J Stroke. 2008;3(2):105–16. 48. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: A systematic review. Age Ageing. 2008;37(5):505–12. 49. Mardjono M, Sidharta P. Mekanisme Gangguan Vaskular Susunan Saraf. In: Neurologi Klinis Dasar. Jakarta: Dian Rakyat; 2010. 50. Bertolini G. Canine ischaemic stroke: Current status and future directions. Vet J. 2011;188(1):9–10. 51. Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011;124(3):314–23. 52. Departemen Kesehatan RI. Riset Kesehatan Dasar. Jakarta: Badan Penelitian dan Pengembangan Kesehatan, Departemen Kesehatan RI; 2013. 53. Al R H, R H, S K, M MT. Buku Ajar Neurologi. Jakarta: Departmen Neurologi Fakultas Kedokteran Universitas indonesia; 2017. 54. Mohr J, Wolf P, Choi D, Weir B. Stroke : Pathophysiology, Diagnosis, and Management. 4th ed. London: Churchill Livingstone; 2004. 55. Stam J. nejm CVT article. 2005;1791–8. 56. Maas MB, Safdieh JE. Ischemic Stroke: Pathophysiology and Principles of Localization. Neurology. 2009;13(Part 1):1. 57. Wibowo S, Ghofir A. Farmakoterapi Stroke Prevensi Primer dan Sekunder dalam Farmakoterapi dalam Neurologi. Jakarta: Salemba Medika\; 2001. 58. Feigin V. Stroke. Jakarta: Bhuana Ilmu Populer; 2006. 59. PERDOSSI. Pedoman Penatalaksanaan Stroke. Jakarta: Himpunan Dokter Spesialis Saraf Indonesia; 2011. 60. Presley B. Penatalaksanaan Farmakologi Stroke Iskemik Akut. Bul Rasional [Internet]. 2013;12(1):6–8. Available from: http://repository.ubaya.ac.id/21378/1/Rasional Vol 12 No 1.pdf 61. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Vol. 49, Stroke. 2018. 46–110 p. 62. Statin | PIO Nas [Internet]. [cited 2021 Feb 23]. Available from: http://pionas.pom.go.id/ioni/bab-2-sistem-kardiovaskuler-0/210-hipolipidemik/2104-statin 63. Aman A, Soewondo P, Soelistijo S. Pengelolaan Dislipidemia di Indonesia. Jakarta: PB PERKENI; 2019. 64. Botham K, Mayes P. Pengangkutan dan Penyimpanan Lipid. 27th ed. Jakarta: Penerbit Buku Kedokteran EGC; 2009. 65. Cholesterol N, Program E. Understanding cholesterol levels. Postgrad Med. 2000;108(7):125–6. 66. Kementerian Kesehatan. PERATURAN MENTERI KESEHATAN REPUBLIK INDONESIA NOMOR 4 TAHUN 2019. 04 Republik Indonesia; 2019. 67. Illahi JFR. Evaluasi Rasionalitas Penggunaan Obat Neuroprotektif Pada Pasien Stroke Iskemik di Rumah Sakit Stroke Nasional Bukittinggi. Universitas Andalas; 2020. 68. Hasanah I. Pengaruh Pemberian Antiplatelet Terhadap Penilaian Status Fungsional Pasien Stroke Iskemik di Rumah Sakit Stroke Nasional Bukittinggi. Universitas Andalas; 2020. 69. Wayunah W, Saefulloh M. Analisis Faktor Yang Berhubungan Dengan Kejadian Stroke Di Rsud Indramayu. J Pendidik Keperawatan Indones. 2017;2(2):65. 70. Sultradewi Kesuma NMT, Krismashogi Dharmawan D, Fatmawati H. Gambaran faktor risiko dan tingkat risiko stroke iskemik berdasarkan stroke risk scorecard di RSUD Klungkung. Intisari Sains Medis. 2019;10(3):720–9. 71. Budi H, Bahar I, Sasmita H. Faktor Risiko Stroke Pada Usia Produktif Di Rumah Sakit Stroke Nasional (Rssn) Bukit Tinggi. J Persat Perawat Nas Indones. 2020;3(3):129. 72. Sofyan AM, Sihombing IY, Hamra Y. Hubungan Umur, Jenis Kelamin, dan Hipertensi dengan. Medula. 2015;1(1):24–30. 73. Polyclinic N, Abidin Z, Aceh B. Hubungan Derajat Stroke Terhadap Status Kognitif Pada Pasien Stroke Iskemik Di Poliklinik Saraf Rumah Sakit Umum Daerah dr . Zainoel Abidin Banda Aceh Relationship Degree Stroke on The Cognitive Status Patients Ischemic Stroke. 2017;2:61–7. 74. Pasaribu DMR, Tedjasukmana R, Gu HJA. Faktor-Faktor yang Memengaruhi Pengetahuan Masyarakat tentang Stroke di RT 010 RW 03 Kelurahan Tanjung Duren Selatan Jakarta Barat Factors Affecting Community Knowledge About Stroke in RT 010 RW 03 Tanjung Duren Selatan Sub-District Wes. Artik Penelit. 2018;42. 75. Widyaswara Suwaryo PA, Widodo WT, Setianingsih E. Faktor Risiko yang Mempengaruhi Kejadian Stroke. J Keperawatan. 2019;11(4):251–60. 76. Siti Rohmatul Laily. Hubungan Karakteristik Penderita Dan Hipertensi Dengan Kejadian Stroke Iskemik. J Berk Epidemiol. 2017;5(1):48–59. 77. Ihsan S, Leorita M, Daud IY. Efektivitas Terapi Statin pada Pasien Pasca Stroke Iskemik (Effectiveness of Statin Therapy in Ischemic Post Stroke Patients). Pharmauho J Farm [Internet]. 2020;6(1):27–32. Available from: http://ojs.uho.ac.id/index.php/pharmauho/article/view/11532 78. Praja DS, Hasmono D, Syifa N. Studi Penggunaan Obat Neuroprotektan Pada Pasien Stroke Iskemik. Pharmacy. 2013;10(2). 79. Fatoni R, Gofir A, Sugiyanto. Comparison of the Benefit of Antiplatelet of Aspirin-Clopidogrel Combination with a Single Aspirin in Ischemic Stroke. J Manaj dan Pelayanan Farm. 2014;257–63. 80. Juwita DA, Almasdy D, Hardini T. Evaluation of Antihypertensive Drug Use on Ischemic Stroke Patients at National Stroke Hospital Bukittinggi. Indones J Clin Pharm. 2018;7(2):99–107. 81. Yoon SS, Dambrosia J, Chalela J, Ezzeddine M, Warach S, Haymore J. Rising statin use and effect on ischemic stroke outcome. BMC Med. 2004;2:1–7. | |
| local.eprints.dir | disk0/00/09/60/03 | |
| local.eprints.division | 10 | |
| local.eprints.id | 96003 | |
| local.eprints.type | thesis/diploma | |
| local.eprints.uri | http://scholar.unand.ac.id/96003/ | |
| local.fakultas | Fakultas Farmasi | |
| local.thesis.level | Skripsi |
